Welcome to our dedicated page for Carecloud news (Ticker: CCLD), a resource for investors and traders seeking the latest updates and insights on Carecloud stock.
CareCloud, Inc. (Nasdaq: CCLD) generates frequent news as a healthcare technology company focused on AI-powered and technology-enabled solutions for medical practices, hospitals, and health systems. Its announcements highlight developments in revenue cycle management (RCM), electronic health records (EHR), practice management (PM), analytics, patient experience management (PXM), digital health, and artificial intelligence (AI).
News coverage for CareCloud often features product launches and AI initiatives. Recent examples include the full launch of stratusAI Desk Agent, an agentic AI phone receptionist designed to automate patient phone interactions and integrate with EHR and PM systems, and updates on stratusAI Voice Audit, a conversational intelligence platform that analyzes patient calls and provides performance metrics and insights.
Investors and healthcare professionals can also follow acquisition and partnership announcements. CareCloud has reported acquiring Medsphere Systems Corporation, bringing the Wellsoft emergency department information system into its portfolio, and entering into an agreement to acquire HFMA’s MAP App, a hospital benchmarking tool for revenue cycle performance, supported by a long-term joint marketing partnership with the Healthcare Financial Management Association.
Another major category of news involves financial results, guidance, and capital structure updates. CareCloud issues quarterly earnings releases, updates revenue guidance, and discusses profitability, cash flow, and the impact of acquisitions. The company also publishes information on preferred stock dividends, including its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (CCLDO) and plans to address accumulated dividends through structured payment programs.
Governance and regulatory updates, such as SEC filings describing material events, board composition changes, and Nasdaq listing rule compliance matters, appear in the news flow as well. For ongoing insight into how CareCloud is evolving its AI strategy, expanding in the hospital IT market, and managing its financial profile, readers can use this page as a centralized feed of company press releases and related coverage.
CareCloud (Nasdaq: CCLD) will report first quarter 2026 financial results before market open on May 7, 2026 and host a conference call at 8:30 a.m. ET.
Investors can join via live webcast and download slides at ir.carecloud.com/events. Audio-only dial‑in options and a replay available about three hours after the call.
CareCloud (Nasdaq: CCLD) reaffirmed its previously issued financial guidance after completing a capital structure simplification on April 16, 2026.
Key actions include closing a $50 million credit facility and redeeming 100% of Series B preferred stock. The company reports ~$130 million revenue and ~$30 million annualized adjusted EBITDA, citing improved financial flexibility and institutional support for its next growth phase.
CareCloud (Nasdaq: CCLD, CCLDO) closed a $50 million credit facility on April 13, 2026, with Citizens Bank and Provident Bank and will fully redeem 100% of its outstanding 8.75% Series B preferred stock on May 15, 2026.
The redemption covers 1,511,372 shares at a Total Redemption Price of $27.52 per share, eliminates roughly $3.2 million in annual preferred dividends, and simplifies the capital structure while preserving non-dilutive institutional financing and liquidity.
CareCloud (Nasdaq: CCLD) announced a new partnership with Arkansas Otolaryngology Center to deploy AI-enabled practice management and revenue cycle management (RCM) solutions across the multi-location ENT practice.
The collaboration will deliver AI-powered claims management, automated denial prevention, coding education, real-time dashboards, and AI-driven financial analytics aimed at accelerating revenue capture and improving clean claim rates, with the company emphasizing reductions in days in accounts receivable and enhanced operational transparency.
CareCloud (Nasdaq: CCLD) will present at the 2026 AAPPR Annual Conference in Orlando, April 13–15, showcasing its Marketware physician strategy platform and a soon-to-launch AI update.
Marketware aims to improve pipeline visibility, accelerate time-to-fill, match clinical candidates to best-fit roles, and measure recruitment ROI. The presentation, “The Right Data, Right Now: Recruitment Reporting That Matters,” will highlight real-time pipeline visibility, actionable workforce strategy, and ROI from recruitment investments.
CareCloud (Nasdaq: CCLD) highlighted the completed Preferred A conversion and progress toward simplifying capital structure. The March 6, 2025 conversion issued ~26 million common shares, raising total common shares from ~16 million to ~42 million. The company reaffirmed prior financial guidance and cited recurring revenue and strong cash flow.
CareCloud noted a recent closing price of $3.49 (March 27, 2026) and said ~3 substantial Preferred A holders remain outstanding; ~ $40 million of Series B preferred remains non-convertible.
CareCloud (Nasdaq: CCLD) is showcasing its enhanced MAP App at the HFMA Revenue Cycle Conference in Arlington, March 19, 2026, demonstrating updates made since acquiring the platform from HFMA.
The company will host a networking happy hour on March 19 and a live webinar on April 7, 2026 at 1:00 PM ET to review product updates, roadmap, and use cases.
CareCloud (Nasdaq: CCLD) will participate in the 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum on March 17, 2026, featuring a company fireside chat streamed live to registered attendees.
CareCloud recently reported full-year 2025 results: its first full year of positive EPS since IPO, exceeded its upsized revenue forecast range, and increased free cash flow by more than 500% over three years. A replay will be available at the company investor relations site.
CareCloud (Nasdaq: CCLD) will ring the Nasdaq Closing Bell on May 19, 2026 and host its 2026 Analyst Day at the Nasdaq MarketSite in New York City. The event will showcase new AI-powered products and a management business update on strategic priorities.
The announcement highlights CareCloud reporting its first full year of positive EPS since its IPO 12 years ago and a roughly 18% rise in its common stock over two trading days after release of full-year 2025 results.
CareCloud (Nasdaq: CCLD) reported full‑year 2025 revenue of $120.5M (+8.7% YoY), GAAP net income of $10.8M (+37.5% YoY) and its first full‑year positive GAAP EPS since its 2014 IPO of $0.10. The company closed acquisitions including Medsphere, entered inpatient software, launched AI products, generated $28.6M cash from operations and repaid its credit line.
Management issued 2026 guidance: $128–$132M revenue, $29–$31M adjusted EBITDA and GAAP EPS of $0.20–$0.23.